Authors: | Castillo, J. J.; Libby, E. N.; Ansell, S. M.; Palomba, M. L.; Meid, K.; Flynn, C. A.; Leventoff, C.; Hergott, C. B.; Sewastianik, T.; Morgan, E. A.; Carrasco, R.; Fromm, J. R.; Yang, G.; Hunter, Z.; Treon, S. P. |
Article Title: | Multicenter phase 2 study of daratumumab monotherapy in patients with previously treated Waldenstrom macroglobulinemia |
Keywords: | bortezomib; dexamethasone; therapy; expression; consensus panel recommendations; 2nd international workshop; cd38 |
Journal Title: | Blood Advances |
Volume: | 4 |
Issue: | 20 |
ISSN: | 2473-9529 |
Publisher: | American Society of Hematology |
Date Published: | 2020-10-27 |
Start Page: | 5089 |
End Page: | 5092 |
Language: | English |
ACCESSION: | WOS:000582796200012 |
DOI: | 10.1182/bloodadvances.2020003087 |
PROVIDER: | wos |
PMCID: | PMC7594378 |
PUBMED: | 33085756 |
Notes: | Article -- Source: Wos |